## **The British Society for Medical Mycology** # **Annual General Meeting of the British Society for Medical Mycology** ## **Monday 8[th] September 17:30 – 18:30** ## **The Assembly House, Norwich** ## **1) Apologies for absence** _Apologies were received by Thomas Rogers, Ruth Ashbee, Silke Schelenz, Rebecca Gorton, Alyssa Hudson, Elena Rosselletti._ _Present in the Room: President Malcolm Richardson (MR), General secretary Margherita Bertuzzi (MBe), BSMM treasurer Lily Novak Frazer (LNF), Meeting secretary Dora Corzo Leon (DCL), Junior Rep Norman van Rhijn (NvR), local organiser Stefan Bidula and Issy Storer, Lottie Brown, Julian Naglik, Riina Richardson, Simon Johnston, George Harrison_ _Present online: Neil Gow_ ## **2) Minutes from Annual General Meeting held 10[th] June, Cardiff** _Minutes seconded by JN and RR_ ## **3) Executive committee nominations (Margherita Bertuzzi)** _MBe announced that from September 2025, new President Prof Riina Richardson (Malcolm Richardson exiting – MBe thanked for his work), new Treasurer Elect (Dr Norman van Rhijn), and new Junior Representative (Thomas Williams – MBe thanksed exiting Junior Rep NvR for his work). Next roles to look for, with a September 2027 start: General Secretary, Meeting Secretary, Clinical Junior Rep and one Executive. MR expressed his huge gratitude towards LNF for her hardwork as treasurer in the past years. MBe reiterated, as well as all the members present._ ## **4) President’s report (Malcolm Richardson)** MR thanked all exiting Exec members, in particular LNF and reported on the ID:IOTS podcasts, our social media and the work of the BSMM working groups. In the interest of time, reports from the leads were not read but appended here. ## _**Report from the Chair of the BSMM working group on the Best practice guidance**_ _The working group has had an extremely successful year, and I am pleased to report that the manuscript: British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases: 2025 update has been accepted for publication by the Lancet Infectious Diseases journal on the 4.9.2025._ Version No.: Status.: Active > Form No.: BSMM-F-04 Effective Date: 27/09/2021 Registered Charity No: 1190926 Author: ## **The British Society for Medical Mycology** _We received very positive comments from the 5 reviewers:_ _… This is a very well written manuscript, it will be useful to the reader and treating physicians. Great figures and tables, and the clinical scenarios a are wonderful addition….._ _… Congratulations on this clear and well-written manuscript…_ _… The manuscript is of really high interest to guide practice in medical mycology diagnosis in hospital setting…_ _At this point I would like to thank the BSMM committee for trusting me to lead the working group again._ _It has been busy journey, and I would also like to thank my co-authors for their hard work, immense commitment, patience, sharing their valuable expertise for this project. It has been a real pleasure to work with everyone. My special thanks is also going to David Denning who has stood by my side providing invaluable support, expertise and input throughout this project._ _The 2015 guidance has already formed the basis of the ECMM auditable standards for laboratory excellence. We are hoping that this BSMM UpToDate Best Practice guidance which is incorporating fresh new aspects will continue to help laboratory as well as clinical staff to keep raising the standards for diagnostic mycology and ultimately will help to improve patients’ outcomes._ _Kind regards_ _Dr. Silke Schelenz_ ## _**Report from the Chair of the BSMM TDM guidelines working group**_ _The group have now completed the first and second round screening of all the literature. The first-round screening was carried out by the group as a whole and the second-round screening was carried out by the people allocated to write each section. Once completed the literature was exported from Rayyan as Word and Excel files and sent to each group._ _The individual groups are now working on reading the literature and drafting the individual sections for the guidelines. It was decided that the guidelines will be written to answer 7 questions for each antifungal as follows:_ _1. Do we need to use TDM for drug X; if so in which populations?_ _2. What is the trough concentration for efficacy?_ _3. Do we need to perform TDM to prevent toxicity, and if so, what is the target concentration?_ _4. What is the recommended timing for TDM samples?_ _5. How should dose adjustments be performed for out-of-range results?_ _6. What specific risk factors may be present that could lead to out-of-range results (e.g. interacting drugs, genetic polymorphisms)?_ Version No.: Status.: Active > Form No.: BSMM-F-04 Effective Date: 27/09/2021 Registered Charity No: 1190926 Author: ## **The British Society for Medical Mycology** _7. Are there specific drug exposure issues in ‘special populations’ (e.g. ECMO, dialysis, ICU, TPN, cystic fibrosis) for drug X and if so, how should they be managed?_ _We aim to have a draft manuscript completed by the end of the year._ _Ruth Ashbee, Sept 2025_ - **5)** Scientific meetings (Dora Corzo Leon) ## _**DCL reported on Norwich 2025**_ Version No.: Status.: Active > Form No.: BSMM-F-04 Effective Date: 27/09/2021 Registered Charity No: 1190926 Author: ## **The British Society for Medical Mycology** Status.: Active Version No.: > Form No.: BSMM-F-04 Effective Date: 27/09/2021 Registered Charity No: 1190926 Author: ## **The British Society for Medical Mycology** Version No.: Registered Charity No: 1190926 Status.: Active > Form No.: BSMM-F-04 Effective Date: 27/09/2021 Author: ## **The British Society for Medical Mycology** Version No.: Status.: Active > Form No.: BSMM-F-04 Effective Date: 27/09/2021 Registered Charity No: 1190926 Author: ## **The British Society for Medical Mycology** _During the AGM, it was mentioned that perhaps Birmingham could host 2027 and we will follow up on this_ . ## **6) T ’ (Lily Novak-Frazer)** Version No.: Status.: Active > Form No.: BSMM-F-04 Effective Date: 27/09/2021 Registered Charity No: 1190926 Author: ## **The British Society for Medical Mycology** Version No.: Status.: Active > Form No.: BSMM-F-04 Effective Date: 27/09/2021 Registered Charity No: 1190926 Author: ## **The British Society for Medical Mycology** Version No.: Status.: Active > Form No.: BSMM-F-04 Effective Date: 27/09/2021 Registered Charity No: 1190926 Author: ## **The British Society for Medical Mycology** Version No.: Status.: Active > Form No.: BSMM-F-04 Effective Date: 27/09/2021 Registered Charity No: 1190926 Author: ## **The British Society for Medical Mycology** Version No.: Registered Charity No: 1190926 Status.: Active > Form No.: BSMM-F-04 Effective Date: 27/09/2021 Author: ## **The British Society for Medical Mycology** _**Treasurer’s report for financial year ended 31st August 2024**_ _These are the financial statements for the British Society for Medical Mycology for the year ending 31st August 2024. This is the fourth set of accounts after converting our Society to a Charitable Incorporated Organisation (CIO) in 2021 and consists of a full 12 months’ worth of accounts._ _The Independent Examiner’s Report to the Trustees of the British Society for Medical Mycology is on the second page. This report concludes that accounting records are in accordance with accounts regulations, and that no unusual items or disclosures in the accounts seeking explanation came to the examiner’s attention._ _These accounts have also been submitted to the Scottish and English/Welsh Charity commissions in accordance with the regulations governing charities in the UK._ _The statement of financial activities is broken down in the seven-page report, which will be circulated to our membership imminently. My apologies for this delay._ _Page 3 of the accounts is a summary of the society’s income and expenditure from 1st September 2023 to 31st August 2024. The details of this income and expenditure are found in the numbered Notes on pages 5-7 of the accounts. Where available, the figures for 2023 are shown on the far right for comparison. The figures shown in the accounts do not include VAT._ _The income for 2024 (page 3) consisted of subscriptions amounting to £3,115 (down considerably from £5,162 in 2023)._ _The membership subscription payment rate had improved in 2023 from the value in 2022 with the introduction of a new payment platform accessed directly from the BSMM web site. So, it’s a little disappointing that the number of subscriptions is down in 2024, considering its value for money. We urge all members to support your Society by visiting the web site to renew their membership in this manner if they have not done so already._ Version No.: Status.: Active > Form No.: BSMM-F-04 Effective Date: 27/09/2021 Registered Charity No: 1190926 Author: ## **The British Society for Medical Mycology** _As a reminder full membership is £30 per annum while student membership is £75 for 3 years. Membership allows travel award funding possibilities._ _This platform works on automated renewal so once you have subscribed, your card details remain anonymised on the system for future membership payments. There are still 4 current full members who still pay by bank transfer, which is not the favoured approach. Of course, one of the pitfalls of the automated system is that if you card expires, you will have to renew with a new card or else your membership lapses. A second snag is that if you no longer wish to be a member, you must actively seek cancellation. A few members have cancelled their membership with a stop payment; I urge anyone thinking of cancelling their membership to contact myself or the general secretary so that we can intervene, to avoid extra charges the charity must try to avoid. My thanks go to Margherita Bertuzzi and Norman van Rhijn, both of whom are key in maintaining membership and effective payment, respectively._ _The other stream of income is from annual meetings. Thank you to the organisers, sponsors and participants of the Cardiff 2024 meeting, which was very successful scientifically. The negative surplus does not reflect the dedication of the meeting organisers; however, it was predicted at last’s year’s AGM. The arrears due to delayed payment of 2023 and 2024 meeting expenses and travel grants, and to some extent delayed sponsor payments, are reflected in the 2024 accounts. As a result, together with reduced subscriptions, the total income of the BSMM for 2024 was_ _**almost £13k in deficit (compared to £13,028 in 2023)** ._ _The expenses of the Society are summarised in the lower half of page 3 and in more detail on Page 5._ _The Management and Administration costs amounted to £7865 in 2024 (compared to £2689 in 2023), reflecting increased Travel and IT costs, perhaps a consequence of increased activities and travel in the post-COVID and certainly inflation._ _Although there were two Glyn Evans Mycology awards taken up again in 2024, these will be accounted for in next year’s accounts. The society increased its allocation of Travel Grants in 2024 to £3449 (up from £2687 in 2023). Included in these accounts is the society’s support of 5 Travel Grants for the Cardiff meeting in 2024 and 4 for the Manchester meeting (all worth £200 each). In addition, the Society supported 8 prizes for these 2 BSMM meetings. A further 3 Travel Grants were awarded for attendance of European or international meetings (£1200) in this financial period. Although submissions for access to travel grants has increased moderately over the last 2 years, we encourage, particularly our student members, to apply for travel grants, especially the Glyn Evans Mycology award._ _A detailed look at the annual meetings activity is shown on Page 6._ _Here you can see the contrast between the income generated from delegate fees in 2023 and 2024 that partially explains the meetings deficit. Together the decreased sponsorship and increased venue costs compound the negative bottom line. Sponsorship will continue to be an issue, as has been experienced this year with the pull out of one of the BSMM’s major contributors._ _The balance sheet of the Society is shown on page 4 of the accounts and details the bank, PayPal and Stripe accounts held by the BSMM. The BSMM finished 2024 with a_ _**net worth of £197,093** (£221,396 in 2023)._ Version No.: Status.: Active > Form No.: BSMM-F-04 Effective Date: 27/09/2021 Registered Charity No: 1190926 Author: ## **The British Society for Medical Mycology** _I would like to thank Mr Keith Thomson of Gardner and Partners Accountants in Aberdeen, who has been a very supportive accountant for the BSMM over the last 19 years, and who has patiently continued to answer many questions in my second year as Honorary Treasurer._ _These financial statements confirm that in 2024 our Society returned to its previous activity levels and expanded its supportive funding aims._ _The modernisation of the BSMM platforms has continued to benefit record-keeping at the society - we thank our Junior Representative, Normal van Rhijn, for continued support of the digital systems used for membership and the website._ _Over the last year, I have continued fulfilling the accounting requirements for the Society, including HMRC, VAT and Charity Commission requirements. Unfortunately, due to family bereavements, I have not made the banking strides promised at the last AGM: there remains the urgent issue of securing two more saving accounts and to expand the society’s investment portfolio to enable earnings on BSMM capital and simultaneously protect and future proof the Society’s finances._ _Our shared concern should be how to retain and increase our membership considering one possibility, which is to raise the cost of membership to continue to support meetings. Uptake of travel grants has improved, and some headway has been made in supporting popular podcasts, which contribute to the modern mycology educational experience. Our collaboration with the University of Exeter on the MSc in Medical Mycology has progressed significantly with the support of our members. As the course goes into its fourth year, discussions between the Society and the University of Exeter must be prioritised on how to support its students via educational grants. Our joint educational aims to further mycology training will hopefully also yield longer-term financial benefits to the Society and feed into its membership._ _Another concern is the cost of meetings in the face of decreased sponsorship and inflation, which the society must address. How is open for discussion._ _Finally, I would like to thank the Executive Committee members and meeting organisers that I have had the privilege of working with this last year. Your help and support have been invaluable. I look forward to achieving the remaining tasks of my post in my last year while providing guidance to the next honorary secretary._ _Norwich, 8th September 2025_ _Dr Lily Novak Frazer_ _Honorary Treasurer for the British Society for Medical Mycology_ ## **7) ’ (Margherita Bertuzzi)** - **a.** _Update on membership 12 life/honorary and 175 members_ - **b.** _Newsletter MBe reported this has started again in an email format; the plan is to do this every two months and she will be seeking help from the new Junior representative._ - **c.** _Travel grants and Glynn awards_ Version No.: Status.: Active > Form No.: BSMM-F-04 Effective Date: 27/09/2021 Registered Charity No: 1190926 Author: ## **The British Society for Medical Mycology** ## _Specific for Norwich_ _Alicja Szkolnik £ 78.15 Jack Gregory £ 111.63 Thomas Easter £ 200 Edoardo Tancredi £ 200 Sagynayeva, Aidana £ 200 Mohyeddin Afrashteh £ 200 Alison Gifford £ 200_ _Others Arnab Pradhan Candida and Candidiasis 2025 conference £350 Dora Corzo Leon ISHAM 2025 £500_ ## **d.** Membership of the Executive _See above_ ## **8) BSMM MSc/Diploma/ Certificate Course (Mark Ramsdale)** Status.: Active Version No.: Registered Charity No: 1190926 > Form No.: BSMM-F-04 Effective Date: 27/09/2021 Author: ## **The British Society for Medical Mycology** Version No.: Status.: Active > Form No.: BSMM-F-04 Effective Date: 27/09/2021 Registered Charity No: 1190926 Author: ## **The British Society for Medical Mycology** Version No.: Registered Charity No: 1190926 Status.: Active > Form No.: BSMM-F-04 Effective Date: 27/09/2021 Author: ## **The British Society for Medical Mycology** Version No.: Status.: Active > Form No.: BSMM-F-04 Effective Date: 27/09/2021 Registered Charity No: 1190926 Author: ## **The British Society for Medical Mycology** ## **9) Update on working groups (Malcolm Richardson on behalf of lead representative of each group)** _See above_ ## **10) Website update (Normal Van Rhijn)** Version No.: Status.: Active > Form No.: BSMM-F-04 Effective Date: 27/09/2021 Registered Charity No: 1190926 Author: ## **The British Society for Medical Mycology** _Not discussed due to time limitations, but there were mentions about the need of dedicated support as it requires a lot of work._ ## **11) AOB** _Nothing raised_ Version No.: Status.: Active > Form No.: BSMM-F-04 Effective Date: 27/09/2021 Registered Charity No: 1190926 Author: THE BRITISH SOCIEfY FOR MEDICAL MYCOLOGY STATEMENT OF FINANCIAL ACTVITIES FOR THE YEAR ENDED 31 AUGUST 2025 Unrestricted Restricted Total Funds Funds 2024 Totsl 2￿28 Notes Sthcriptions Donations SurpFus Exeter MasteTS Course SurplusAnnual Meth"ng Sponsorship from wev¥)us yEars meeting Bank Interest Blcrf)d & Fungi Profft Share HS Reimbursment Book Sales Spon50rsfvip Fungal Registy Joint C¢xtfèrence Profft Share Gfyn Evans m￿l09YAWa￿ F￿d 4560 4560 3115 196 196 -16104 4756 4756 -12989 Expenses Travel Graftts Travel Grants- GW Erdns Mytsjlogy Fund 1750 1750 1578 3449 1576 Dlploma MateriaLs Diploma Staff Costs Diploma Travd Costs Fvngal Registry FIS Speaker5 ExpensÈ$ Book Costs UKCMNCost$ Working Party Candtila Syndrome UCL Bursary K43n8g8ment 8 Adrninlstratlon Costs 8650 8650 7865 Totsl Rèsourc¢ Expenses 10400 1576 11976 11314 Net Incomlng Resoure8s for Year -1576 -7220 -24303 Funds Brought Forward 205782 4689 197093 221396 Funds Carried Forward 200138 -10265 189873 197093 THE BRITISH SOCIEfY FOR MEDICAL MYCOLOGY BALANCE SHEET AS AT 31 AUGUST 2025 2025 2024 Current Assets Stock Stripe Paypal Llowjs CIO Account Cash in Hand Prepayments 1878 48861 41659 104034 71520 41659 68270 5675 187124 196432 Cunvnt Ltabiltl95 VAT A¢crua 4225 476 -1208 547 -2749 461 Net Current ksets 189873 197093 189873 197093 Funds Unrestricted F%Jnds Restrtcted Fund- Glyn Evans Mycology 200138 -10265 205782 -8689 189873 197093 Accounts were approved bythe committee cn the and siqned on their ￿haIrbY Treasu President THE BRJTfsH 50CIEfY FOR MEDICAL MYCOLOGY NOTES TO THE ACCOUNTS FOR THE PERIOO ENDED 31 AUGUST 202S nti Policlets Basis of A£tounttng The actstyJtrt5 have be*n prepar•d underthtt Hlstorfcal Cc*t Con¥*ntiM. Subscriptions Sul>scriptith in¢omo c4mpTisès amtyjrts Tecei¥8d in th8 year. Incomo 20 2024 Subsrrriptiw Interest Donatior Bfuod & FL%ngi Profrtshare FIS Re1m￿jr8*y*nt 3115 4560 3115 ManagemEnt &AdMIr￿stratIOn Costs Commttee Expen5ES Subscriptions Travel Costs Website & Complrter Printing, Postage. Statronery & Adverti5ng Don8￿n$ Spon5crship Trwni Professicnal Fees AttaurrtanByFees Bank Charges Sundry Expenses 49 193 12 835 1761 1878 3000 389 432 7865 THE BRITISH SOCIETY FOR MEDICAL MYCOLOGY NOTES TO YHE ACCOUNTS FOR THE PERIOD ENDED 31 AUGUST 2026 2023 Income D81ogste Fees SpOnso￿h1) Donalw)n Share ofPrnfft Expendllure Ato)mmodation & Caterrng LecturefslDemcfistrobng Expenses aterias Boc&s Anotrary&TethrMcal Costs Sundry Leeds UnNwstyShare of &Jrplus Su￿lUs nua Income De￿gate Fe s[￿￿rshiP 15546 9235 13985 31630 24781 45615 Expenditure Ac£omodation Caterir Speakers Expe￿8$ RoDrn Hire c￿￿r Expenses Gifts 22195 59620 852 1956 143 61719 Surpl -16104 THE BRITISH SOCIETY FOR MEOICAL MYCOLOGY NOTES TO THE Accouprfs FOR THE PERIOD ENDED 31 AUGUST 2026 Fund The fund was created bythe SOC￿10 commerate Gtyn Evans. The award is regarded as an extension ofthe Èxisting travel a%vard 5dJpme 8nd airns to prowde appFKants with finarrtkgl support to vis(t 0th8rlabraknias fortranin9. £1,576 IDqil- 2024lwa5 paKS to 2 ndiw(kJals10-20241. 6 TMv•l Grdnts Travel grants of £1,7501£3,449-20241 was paTrJ to 5 indMduAl$115- 20241. 7 Comrnitttè Mernbers Ex •n5es A totsl of Nil I£Nil- 20241 was reimbursed to memb8rs of the commMt8e during IhÈ hwr. No Honorarium has be￿ paid lo anycommhee members. CHARITY REGISTRATION NUMBERS ENGLAND & WALES 1190926 SCOTLAND SC050556 BRITISH SOCIETY FOR MEDICAL MYCOLOGY FINANCIAL STATEMENTS 31 AUGUST 2025 GARDNER & PARTNERS LTD Chartered Certified Accountants 9 Rosemount Place Aberdeen AB25 2UX BRITISH SOCIETY FOR MEDICAL MYCOLOGY 1190926 & SC050556 INDEPENDENT EXAMINERS REPORT TO THE TRUSTEES OF THE BRITISH SOCIETY FOR MEDICAL MYCOLOGY YEAR ENDED 31 AUGUST 2025 REPORT OF THE INDEPENDENT EXAMINER I report on thc accounts olthe tharity for the year ended 31 August 2024 which are set out on pages I 105. RESPECTIVE RESPONSIBILITIES OF TRUSTEES AND EXAMINER The charily's t￿slee$ arc responsible for tl)e preparation of the accounts in accordance with the temLS of the charilies and trustee investment (Scotland) Act 2(X15 and thc charities accounts (Scotland) regulations 2(K)6. The charity trustees consider that the audit requirement of regulation 10(1) (d) of the accounts regulations does not apply. It is my responsibility to examine the accounts as required under seeiion 44(1) (¢) of the act and io state whether particular matters havc come lo my all¢ntion. BASIS OF INDEPENDENT EXAMINER'S STATEMENT My examination is carried out in accordance with regulation I l of the charities aceounls (Scotland) regulations 2006. An ¢xamiJ)atson includes a revicw of the accounting records kept by the charity and a ¢omparison of the accounts presented with those records. It also includes consideralion of any unusual itcms or disclosures in the accounts, and seeks explanations from the trustets concerning any such D￿tter$. Thc procedures widertaken do not providc aRI the evidence that would bc rcquired in an audit, and consequently I do not express an audit opinion on the view given by the accounts. IIYDEPENDENT EXAMINER'S STATEMEFIT In the ¢ours¢ of ny examination no matter has come to my attention. l. Which gives me reasonable cause to believe that in any material respect the requirements To keep accountlng records in a¢¢ordance with section 44(1) (a) and regulation 4 of the 2006 accounts regulations, and To PTepare a¢coufjts which accord with the accounting records and comply with rcgulaiion 9 of the 2006 ￿￿oUntS regulations have nol been m¢t. or 2. To which in my opinion, attention should be drawn in Order to enable a proper understanding of the accounts to b¢ rea¢hed. Kcith Thomson FCCA Garth)er and Partners Ltd Chartered Certified Accountants 9 Rosemounl Place Aberdeen AB25 2UX 28 May 2026 THE BRITISTrI SoCI￿y FOR MEDICAL MYCOLOGY STATEMEKf OF FINANc￿L ACTVITIES FOR THE YEPR ENDED 31 AUGUST 2025 Unrestrtbxed Restricted Total Funds 2024 Tclal 2023 Nots8 Subscrob'on8 Donativ Surplus Exoter Masters Courne Surplus Amual Meeung Sponsorship frorn prevKJUS yBars me¢ling Bank Intèr•st Blo(xJ & Fungi Proft Sl FIS Rtiimbursment Book Sales Sponsorshlp Fungal Reglstry jointconferen￿ Profil Share Ev•n$ M￿lOgyAW8rd Fund 4560 3115 196 -16104 4756 4756 -12989 Tr8vel Grants Tfayol Grants- EvAftA My¢otogy Fund 1750 1750 1576 3449 1576 DiF4oma MaterfaLs Diploma siaff C¢xqts DlptDma Travel Cosis Fung￿ Registry FIS Speakers EXPe￿eS Book Costs UKCMN Costs Working Poty c￿d￿l8 Syndror UCL BLWS8ry Man&Jemenl & Admlnlstratlon Costs 8650 7865 Totsl Resource E>pertses 1040Q 1576 11976 11314 Net I￿ornIng Re8ourw for Yèar -1576 -7220 .24303 Fund8 Br(rtJght FcThwd 205782 4689 197093 221396 Funds Carriod Forward 2￿1 -10265 189873 197093 THE BRMSH SOCIETY FOR MEDICAL MYCOLOGY ALANCE SHEET A8 AT 31 AUGUST 2025 Notes 2￿25 2024 CU￿nI knetB Stock Stripe Paypal Uoyds CIO AcC￿jnt Cash In H8nd Pr￿￿MentS 1878 48861 41659 1Ck1034 71520 41659 68270 5675 187124 196432 Cuwent Liabilties VAT AwuaLs -3225 476 -1208 547 -2749 461 Net Current A•￿ts 189873 197093 189873 197093 Funds Unreslrfcted Funds Reslrthd Fund. Glyn Ewans MyCol)gy 200138 -10265 205782 -8689 189873 197093 Accounts were approved bytho c¥mmitb8 on thè and srgn8d on thelr behalf by Treasur PresNJenl THE BRITISH SOCIETY FOR MEDICAL MYCOLOGY NofEs YOTHE ACCOUNTS FOR THE PERK)D ENDED 31 AUGUST 2D25 Bb*h olAGcounllrto The t&¢￿[￿ have beèn prepar8d und•rtho H*ton'eal C051Coftb¥ntion. SubBcrfpflon¥ sub￿￿pI￿n income Ciynprises arno￿ts rethd in Iheyear. In¢omq 2025 Sub8cDploY htere81 De￿a￿or Bknd & Fury Profrtslkwe FIS ReknbJrdm8nt 3115 4560 3115 n•9ement &AAknlnlglretlon Cost* Commftt¢6 Eynses SubsCrbtt¢￿s Trnvel Co¥ts Webs(le & Comp&tsr ExpeThgo8 PAThthg. Postage, Sta￿0￿ry&A￿Prtl*9 Don81i¢n$ SI￿￿0￿ShIP Trnlnlng 49 1761 5720 635 1878 3000 FegB A￿aunt￿1¢Y Fees kCh8 389 432 8650 7865 THE pR￿ISH SOCIETY FOR MEDICAL MYCOLOGY NOTESTO THÉ ACCOUNTS FOR THE PERtOD EtrX>ED 31 AUGUST 292S Dok9ath Fws Srx)n$ttth Donauon Share E¥pendilur* Accommodalon & Cat6dng k4ateiialB Postage. P￿t￿O￿n9, et¢ A￿al￿ry &TethrKC￿ Costs sUr￿ry Glf Loeds UrTher5tyShare of SU￿)j¥ Surplu coma D81898te Fees Sponsorsh 15546 9235 13985 31630 24781 45615 ExpeDdlbK• Artrffiod¥tionand Caterkng Speaker5 Exper￿e5 22195 I￿8 Ott￿r ExF4ns88 Qifts 652 1956 143 24585 61719 .16104 TrE BRifisH SO¢IFfY FOR MEDICAL MYCOLOGY NOTES TOTHE ACCOUPtrs FOR THE PERtOD ENDED 31 AUGUST 2026 TM lund was ¢r•ated by tho S￿￿*1¢0MM￿ GW EvAnÉ. ¥* rÈprtsd 48 an extgn8iai oflhe exlsiing tra¥el Hword Bc*Bme ond Ahs to pro¥rfde appftsntswith Ih8n¢ial supwrt lo other lebrnitrrf88 for traknlng. £1.576 I£NI. 20241 to 2 indhrfthJ8Js10-20241. rav•1 Gra Travql grant5 CA E1.7501£3.449-20241 was paKI ts 5 kndMduats115-2024}. A tolal of Nll I£NII- 21MI was r8rnbu￿ed lo membET5 of the committ08 durfng ihs year. No HonThum ha5 been p8ld to anyrA)mmlt*b mÉmt*r*